Buse Kayhan

Buse Kayhan

Auto-generated profile, based on publicly available information

Buse Kayhan

Ege Universitesi

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in The Korean Journal of Pain
Verified
Journal Article
Open access
PDF file
NDNeslihan Düzenli
Neslihan Düzenli
SÜSibel Ülker
Sibel Ülker
GŞGülgün Şengül
Gülgün Şengül
BKBuse Kayhan
Buse Kayhan
AÖAytül Önal
Aytül Önal
Neslihan Düzenli, Sibel Ülker, Gülgün Şengül, Buse Kayhan, and Aytül Önal. Korean J Pain 2022;35:66-77. https://doi.org/10.3344/kjp.2022.35.1.66

3 July 2025
Verified
Preprint
Open access
BKBuse Kayhan
Buse Kayhan
AŞAylin Şendemir
Aylin Şendemir
GSGulgun Sengul
Gulgun Sengul
Spinal cord injury (SCI) results in devastating neurological deficits due to the disruption of motor, autonomic, and sensory functions. In this study, we aimed to investigate the neuroregenerative effects of graphene in in vitro models of SCI, focusing on mechanical and chemical injury. NSC-34 motor neuron-like cells were employed in mechanical and chemical injury models to simulate SCI. Mechanical injury was induced using a scratch model, while chemical injury was achieved through exposure to alpha-kainic acid (α-KA). Graphene was applied at varying concentrations to assess its efficacy in promoting cell viability and scratch closure. Immunohistochemical staining was conducted to examine neurite outgrowth and neuronal marker expression. In the mechanical injury model, NSC-34 cells exhibited gradual migration and proliferation, leading to scratch closure within three days. Chemical injury with α-KA resulted in dose-dependent cytotoxicity, with an effective dose of 70 µM. Treatment with graphene significantly improved cell viability, accelerated scratch closure, and enhanced expression of neuronal markers. Our findings demonstrate the promising neuroregenerative and neuroprotective effects of graphene in in vitro models of SCI. Graphene holds potential as a therapeutic agent for SCI, offering opportunities for enhancing neural regeneration and improving patient outcomes.